Mobix Labs, Inc

Mobix Labs, Inc. designs and develops semiconductor and RF connectivity solutions, with a focus on mmWave wireless ICs and related products for defense, aerospace, industrial, commercial, and medical applications. The company has also expanded through acquisitions, adding capabilities in aerospace, military, defense, medical, and EMI-related markets.

−376,6 %

50,5 %

−465,4 %

+53,9 %

0.24

0.19

— Mobix Labs, Inc
%
mmWave wireless ICs35% Millimeter-wave integrated circuits under development and commercialization for wireless connectivity applications.
Defense and aerospace RF solutions40% Semiconductor and connectivity products sold into defense, aerospace, and mission-critical systems.
EMI solutions15% Electromagnetic interference-related products and solutions added through acquisition.
Industrial and commercial applications10% Products used in industrial, commercial, and other non-defense end markets.

Mobix Labs sells primarily to organizations that integrate its products into defense, aerospace, commercial,...

  • Defense and aerospace integratorsprimary

    Buy RF, connectivity, and EMI-related components for mission-critical platforms and systems.

  • Commercial and industrial customerssecondary

    Buy semiconductor and connectivity products for non-defense applications where performance and reliability matter.

  • OEMs and ODMsemerging

    Potential future buyers of mmWave ICs once products complete development and enter production.

  • Large strategic account customersprimary

    Anchor customers such as Leidos that currently represent a substantial share of revenue.

The company is headquartered in the United States and appears to generate most of its business through U.S...

  • United States is the core market and operating base
  • Revenue concentration suggests limited near-term international diversification
  • Offshore suppliers create exposure to Taiwan and Asia-based manufacturing
  • Cross-border sourcing adds customs, trade, and currency risk
  • Geographic exposure matters because supply disruptions can delay product delivery

Mobix Labs is focused on commercializing mmWave wireless technology while broadening its product base through...

01
Commercialize mmWave wireless productsshort-term

Future growth depends on converting development work into revenue-generating products.

02
Diversify customer concentrationmedium-term

Revenue is highly dependent on a small number of customers, increasing volatility and downside risk.

03
Integrate acquisitions and adjacent capabilitiesmedium-term

Acquisitions can add products and market access, but only if integration is successful.

Mobix Labs faces concentrated-customer risk, product-development risk, and going-concern/capital-raising risk typical...

critical

Customer concentration

Leidos accounted for about 50% of fiscal 2025 net revenue, so losing that account would materially reduce sales.

Scope
Single-customer dependence
Materiality
high
critical

Capital raising and going concern

The company expects to need additional financing and has disclosed substantial doubt about its ability to continue as a going concern.

Scope
Liquidity and dilution risk
Materiality
high
high

Early-stage commercialization risk

The company is still developing mmWave products, and demand timing/scale is uncertain.

Scope
mmWave wireless products
Materiality
high
high

Supply chain disruption

Mobix Labs relies on third-party suppliers, including offshore sources, which can be affected by geopolitical and logistics issues.

Scope
Taiwan and other overseas suppliers
Materiality
medium
medium

Customer qualification and adoption risk

Semiconductor customers often require lengthy qualification, delaying revenue conversion.

Scope
Design-in cycle timing
Materiality
medium
Earnout liability fair value
Non-cash gains or losses in the income statement
Liability-classified warrants
Can add volatility to net income
Goodwill impairment
Potential large non-cash impairment charges
Long-lived asset impairment
Reduces asset values and earnings
Stock-based compensation
Affects reported margins and loss levels

: 28.4.2026